Our focus

Through our innovation team, Teva Canada offers specialty pharmaceuticals and healthcare solutions in the following therapeutic areas: central nervous system (CNS), pain care, respiratory and oncology.

CNS and pain

Our CNS franchise provides a complete approach to disease management, offering indispensable medicines (and patient support services) to help patients living with conditions affecting the CNS. Our commitment to high quality products and patient-centred care has allowed us to establish and maintain leadership in this therapeutic area.

Our growing pain care franchise and pipeline will provide essential treatments for patients with chronic neurological disorders. We are proud to be bringing back a measure of quality to the lives of those patients living with pain.

Our global research and development group is developing a focused portfolio of solutions that looks across the spectrum of pain states, including chronic nociceptive pain, cancer pain, chronic neuropathic pain and migraine.

Respiratory

Our respiratory franchise provides high-quality, cost-effective treatment options uniquely designed for people with asthma. Our respiratory pipeline is centred on optimizing respiratory therapies for patients through novel delivery systems and therapies.

We’re also expanding into other respiratory therapy areas. We will continue to build upon our experience in the development, manufacture and commercialization of respiratory medicines for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Oncology

Our oncology franchise exists to provide solutions that advance cancer care and improve the lives of people affected by cancer.

Other therapeutic areas

We also market brands in women’s health and have established partnerships with other Canadian pharmaceutical companies in this area.